POMStrace provides unique tracking features for clinical trials to reduce patient risk. The upgraded POMSnet features multiple language support and better material handling capabilies.
Honeywell has introduced two additions to its POMSnet web-based manufacturing execution system (MES) for the pharmaceutical industry: the latest platform upgrade of POMSnet and POMStrace, a new tracking technology that helps reduce patient risk by improving communication and response time during clinical trials.
POMSnet helps improve pharmaceutical manufacturing performance by controlling and tracking all aspects of production, promoting best practices, and capturing critical data for compliance, quality control and process improvement. The new POMSnet upgrade supports multiple languages and offers improved material handling and new recipe features that can reduce cycle times, roll-out time for new procedures, production errors and compliance costs. The new upgrade features a batch rescaling tool that automatically adjusts recipes to partial batch quantities and includes new weighing methods and dispensing rules for increased accuracy. The system can reduce production errors up to 50%.
The new POMSnet upgrade also includes integration with Honeywell’s Procedure Analyst, an advanced software application that manages information about plans, production and supply chain performance. This integration allows pharmaceutical manufacturers to more effectively troubleshoot their batches for increased operational efficiency.
“There truly is no room for error in pharmaceutical manufacturing, and technology is needed that can help drug makers produce the highest-quality products while maintaining plant safety and meeting very strict regulatory compliance,” said Ashish Gaikwad, global director for Advanced Solutions, Honeywell Process Solutions. “The new POMSnet upgrade was designed to run tighter processes while making the technology easier to use. The new support for multiple languages enables customers worldwide to take advantage of this technology.”
POMStrace reduces the effort to maintain and track inventory records for supplies used in clinical trials. The system provides up-to-date information on supply levels, including patient distribution. It can also reduce potential risks to patients in case of a cancelled or recalled trial by blocking dispensing and providing immediate access to all logistical information. The system produces a traceability record of each patient kit and provides complete accounting for all materials.
For more information contact Debbie Rae, Honeywell Southern Africa, +27 (0)11 695 8000, [email protected], www.honeywell.co.za
© Technews Publishing (Pty) Ltd | All Rights Reserved
printer friendly version